Results of AGM

Summary by AI ^BETAClose X

Fevertree Drinks plc announced that all resolutions were duly passed at its Annual General Meeting held on June 9, 2026. This signifies shareholder approval for the company's proposals, which is a standard procedural event for publicly traded companies and generally has no immediate impact on share price unless specific resolutions were contentious or related to significant financial matters not detailed here.

Disclaimer*

Fevertree Drinks PLC

09 June 2026

9 June 2026

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Results of AGM

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that at the Annual General Meeting held today at 11.00am, all resolutions were duly passed.

Ends

For further information:

Investor queries

Steve Nightingale, Investor Relations Director (Interim) steve.nightingale@fever-tree.com I +44 (0) 7951 849 564

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0) 770 332 9024

Nominated Advisor and Broker - Investec Bank plc

David Flin +44 (0)20 7597 5970 | James Hopton +44 (0) 20 7597 2046

Corporate Broker - Jefferies International Limited

Ed Matthews +44 (0) 20 7029 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233

Notes to the Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers by retail sales value, with distribution to over 95 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END